Please assess the completion status of the following clinical trial:

Trial Title: Mirena or Conventional Medical Treatment for Menorrhagia

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Women between the ages of 18-45 (inclusive) not intending to get pregnant during the next year~* Women complaining of heavy menstrual bleeding over several consecutive cycles~* Women without structural or histological abnormality of the uterus, or with fibroids less than 3 cm in diameter which are causing no distortion of the uterine cavity (eligible for pharmaceutical treatment according to the NICE guideline 2007)~* Informed consent (where required by laws or regulations)~Exclusion Criteria:~* The contraindications and warnings of the respective Summary of Product Characteristics (Mirena, combined oral contraceptives, oral/injectable progestogens, non-steroidal anti-inflammatory drug, or anti-fibrinolytic agent) must be followed.~* Women taking hormone replacement therapy~* Women with symptoms such as intermenstrual or post-coital bleeding, unless an endometrial biopsy has been performed and pathology excluded~* Women with fibroids that are palpable abdominally or who have intra-cavity fibroids and/or whose uterine length as measured at ultrasound or hysteroscopy is greater than 12 cm (NICE guideline 2007)~* Women on anticoagulative therapy or other treatment (including e.g. Copper IUD use) known to cause menorrhagia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Group 1 (Type: None): None
- Group 2 (Type: None): None
- Group 3 (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).